L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation
Authors:
Open Access
- 23 January 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 156 (1) , 161-171
Abstract
Allele variants in the L-carnitine (LCAR) transporters OCTN1 (SLC22A4, 1672 C → T) and OCTN2 (SLC22A5, -207 G → C) have been implicated in susceptibility to Crohn's disease (CD). LCAR is consumed in the diet and transported actively from the intestinal lumen via the organic cation transporter OCTN2. While recognized mainly for its role in fatty acid metabolism, several lines of evidence suggest that LCAR may also display immunosuppressive properties. This study sought to investigate the immunomodulatory capacity of LCAR on antigen-presenting cell (APC) and CD4+ T cell function by examining cytokine production and the expression of activation markers in LCAR-supplemented and deficient cell culture systems. The therapeutic efficacy of its systemic administration was then evaluated during the establishment of colonic inflammation in vivo. LCAR treatment significantly inhibited both APC and CD4+ T cell function, as assessed by the expression of classical activation markers, proliferation and cytokine production. Carnitine deficiency resulted in the hyperactivation of CD4+ T cells and enhanced cytokine production. In vivo, protection from trinitrobenzene sulphonic acid colitis was observed in LCAR-treated mice and was attributed to the abrogation of both innate [interleukin (IL)-1β and IL-6 production] and adaptive (T cell proliferation in draining lymph nodes) immune responses. LCAR therapy may therefore represent a novel alternative therapeutic strategy and highlights the role of diet in CD.Keywords
This publication has 44 references indexed in Scilit:
- Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2−/−) miceMolecular Genetics and Metabolism, 2007
- GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in miceGut, 2007
- Antioxidant and antiradical activities of l-carnitineLife Sciences, 2006
- l ‐Carnitine: a nutritional modulator of glucocorticoid receptor functionsThe FASEB Journal, 2003
- Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat modelGastroenterology, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.Journal of Experimental Medicine, 1995
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995
- Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.Journal of Experimental Medicine, 1994
- Carnitine depletion in peripheral blood mononuclear cells from patients with AIDSAIDS, 1994
- Diet in the management of Crohn's disease.Gut, 1985